SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense investor scrutiny and selling pressure following reports that the company is weighing a massive stock offering to fund its aggressive AI infrastructure expansion. The community remains deeply divided, with some investors viewing the potential dilution as a necessary step to secure compute dominance, while others are aggressively shorting the stock, citing concerns over poor capital allocation, out-of-control capex, and unproven ROI for their AI-heavy strategy.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently facing significant investor frustration as the stock continues to underperform relative to the broader market, despite ongoing aggressive share buybacks and a low P/E valuation. The community remains deeply divided, with some investors betting on a long-term turnaround fueled by structural cost-cutting and potential acquisition interest, while others view it as a stagnant value trap consistently failing to sustain upward momentum.

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Generate Biomedicines Inc

Generate Biomedicines is generating intense community interest following reports of a significant institutional investment, leading to polarized debates over the accuracy of these filings and the firm's long-term potential in the AI-driven drug discovery space. Investors are closely monitoring the stock's volatility and its advanced clinical pipeline while assessing whether the current price levels represent a strategic entry point or a broader market correction.

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is trending as investors weigh its pivot toward AI data center optical interconnect technology against its established defense contracts. The community is actively debating the potential of its partnership with Fabric.AI and speculating on future NDA announcements with major semiconductor firms.

Solidion Technology, Inc. engages in researching, developing and manufacturing battery components and materials, batteries and related energy storage products for the automotive electric vehicle and other markets. The company was founded on June 30, 2023 and is headquartered in Dallas, TX.

Solidion Technology Inc

Solidion Technology Inc (STI) is experiencing extreme volatility driven by a flurry of patent-related announcements for their battery technology, which investors are linking to broader space infrastructure and AI-driven energy demand. While the stock has seen massive gains, the community is intensely divided, with bulls pointing to high short-borrow fees as a catalyst for a squeeze, while bears are expressing concerns over potential share dilution and limited revenue.

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

TRUMP CRYPTO is experiencing significant downward pressure as the community expresses frustration over consistent value depreciation, frequently labeling the asset a scam. Investors are actively debating the token's lack of utility and its association with broader political controversies, leading many to urge others to exit their positions.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is seeing increased attention as investors rotate into consumer staples, attracted by the company's valuation, strong dividend yield, and stabilization efforts under new leadership. The community is actively debating the company's turnaround potential, the impact of management's strategic shifts, and the stock's stability as a defensive hedge against broader market volatility.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is currently attracting intense investor interest as the community weighs its aggressive Bitcoin treasury strategy and the expansion of its 'SATA' preferred stock offering against ongoing volatility in crypto markets. While some investors highlight the stock as a high-growth vehicle for Bitcoin accumulation and digital credit innovation, others express skepticism regarding the company's valuation premiums, dilution risks, and the long-term sustainability of funding treasury operations through high-interest leverage.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending following FDA approval for its xT CDx tumor-only testing platform, a catalyst that has reinforced institutional interest and spurred optimistic discussions about long-term scaling. Despite this, the community remains divided and highly active, with vocal debates surrounding the stock's high short interest, ongoing volatility, and mixed reactions to insider compensation levels.

iShares Trust - iShares India 50 ETF

iShares India 50 ETF

The iShares India 50 ETF is trending amid significant market volatility as investors weigh aggressive economic reforms and long-term growth targets against concerns over currency weakness and geopolitical exposure. The community is actively debating the impact of foreign institutional outflows, fluctuating energy prices, and the country's attractiveness relative to other emerging markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It PR Newswire NEW YORK, May 22, 2026 Issued on behalf of Conexeu Sciences Inc.Companies mentioned: Conexeu Sciences Inc. (NASDAQ...

Evolus to Participate in The Jefferies Global Healthcare Conference

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a...

Evolus Announces Commercial Launch of Estyme Injectable Hyaluronic Acid Gels in Europe

Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme (pronounced...

Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates

Evolus (EOLS) delivered earnings and revenue surprises of +25.93% and +0.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Evolus Q1 Earnings Call Highlights

Evolus (NASDAQ:EOLS) reported first-quarter results that management said reflected a stronger operating model following cost structure changes implemented last year, while reiterating its full-year...

Evolus (EOLS) Q2 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Evolus (NASDAQ:EOLS) Releases Earnings Results, Misses Expectations By $0.02 EPS

Evolus (NASDAQ:EOLS - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The business had revenue of $73.14 million for the quarter, compared to analyst estimates of $72.52 million...

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook

Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the first quarter ended...

Evolus (EOLS) to Release Quarterly Earnings on Monday

Evolus (NASDAQ:EOLS) will be releasing its Q1 2026 earnings after the market closes on Monday, May 4. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-4-evolus-inc-stock...

Evolus, Inc. (NASDAQ:EOLS) Given Consensus Rating of "Moderate Buy" by Analysts

Evolus, Inc. (NASDAQ:EOLS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommenda...

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

EOLSEvolus Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EOLS News